Business Context and Reporting Period
Company: Abbott Laboratories
Filing Type: Form 8-K (Current Report)
Report Date: April 16, 2026
Event: Announcement of First Quarter 2026 results of operations.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification that these results have been announced and are detailed in a separate news release (Exhibit 99.1).
Non-GAAP Measures: The company utilizes non-GAAP financial measures to adjust for unusual or unpredictable factors, including:
- Acquisition-related expenses and accelerated stock-based compensation.
- Restructuring actions and certain regulatory costs.
- Adjustments related to prior recognition of significant non-cash deferred tax benefits.
- Tax benefits from the resolution of prior-year tax positions.
- Excess tax benefits associated with share-based compensation.
- Intangible amortization expense.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the incorporated news release (Exhibit 99.1) for comparative performance details.
Guidance, Outlook, and Risks
Management Commentary: Management states that non-GAAP measures provide useful information for evaluating ongoing business performance and are used internally to monitor business performance. However, the company cautions that these measures should be considered in addition to, and not as a substitute for, GAAP financial measures.
Guidance and Risks: The filing text does not contain specific forward-looking guidance, risk factors, or contingencies beyond the standard caution regarding non-GAAP measures.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated April 16, 2026) for specific Q1 2026 revenue and earnings figures.
- Compare reported GAAP results against the non-GAAP adjustments listed in the filing to understand the impact of one-time items.
- Verify the specific components of "unusual or unpredictable" expenses excluded from non-GAAP calculations.
- Check for any updated full-year guidance provided in the referenced press release.